FDA Clearance Tracker · P160054-S100
HeartMate 3 Left Ventricular Assist System
Last checked: Nov 20, 2026Latest source record: May 23, 2025 (this decision)Source: openFDAMethods & limitations
Decided
May 23, 2025
Approved
Time to decision
81 days
Received Mar 3, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P160054-S100
- Device name
- HeartMate 3 Left Ventricular Assist System
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Pleasanton, CA
- Received
- Mar 3, 2025
- Decided
- May 23, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P160054
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for an update of the HeartMate Touch Communication system, including the off-the-shelf iPad hardware, the iPad operating system, and HeartMate Touch application.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.